photo of

Details

Role Team Leader / Dir. Cord Blood Bank
Research area Stem Cell Medicine

Contact

Available for student supervision
Associate Professor Ngaire Elwood is the Director of the BMDI Cord Blood Bank and Head of the Cord Blood Stem Cell Research Laboratory at the Murdoch Children's Research Institute. Her current research interest is aimed at extending the use of cord blood for cellular therapies, particularly through clinical grade cord blood derived iPSCs and cord blood for cardiac repair..

Ngaire serves as Chair of the AusCord network of public cord blood banks. She is Vice President of the international Board of Directors for the Foundation for the Accreditation of Cellular Therapies (FACT), is a FACT inspector and serves on various FACT committees. Other board and executive appointments include Non-Executive Director on the Board of the National Stem Cell Foundation of Australia, Chair of the Australian Sickle Cell Advocacy Inc, and a member of the Board of the International Society for Cell & Gene Therapy (ISCT). Ngaire serves on the TGA Advisory Committee on Biologicals and the MCRI Institutional Biosafety Committee.

Ngaire has devoted her career to providing improved therapies for the treatment of cancer, leukaemia and other disorders, and is passionate about the therapeutic application of cellular therapies.
Associate Professor Ngaire Elwood is the Director of the BMDI Cord Blood Bank and Head of the Cord Blood Stem Cell Research Laboratory at the Murdoch Children's Research Institute. Her current research interest is aimed at extending the use of cord...
Associate Professor Ngaire Elwood is the Director of the BMDI Cord Blood Bank and Head of the Cord Blood Stem Cell Research Laboratory at the Murdoch Children's Research Institute. Her current research interest is aimed at extending the use of cord blood for cellular therapies, particularly through clinical grade cord blood derived iPSCs and cord blood for cardiac repair..

Ngaire serves as Chair of the AusCord network of public cord blood banks. She is Vice President of the international Board of Directors for the Foundation for the Accreditation of Cellular Therapies (FACT), is a FACT inspector and serves on various FACT committees. Other board and executive appointments include Non-Executive Director on the Board of the National Stem Cell Foundation of Australia, Chair of the Australian Sickle Cell Advocacy Inc, and a member of the Board of the International Society for Cell & Gene Therapy (ISCT). Ngaire serves on the TGA Advisory Committee on Biologicals and the MCRI Institutional Biosafety Committee.

Ngaire has devoted her career to providing improved therapies for the treatment of cancer, leukaemia and other disorders, and is passionate about the therapeutic application of cellular therapies.

Top Publications

  • Elwood, NJ, Zogos, H, Pereira, DS, Dick, JE, Begley, CG. Enhanced Megakaryocyte and Erythroid Development From Normal Human CD34+ Cells: Consequence of Enforced Expression of SCL. Blood 91(10) : 3756 -3765 1998
    view publication
  • Elwood, NJ, Zogos, H, Willson, T, Begley, CG. Retroviral transduction of human progenitor cells: use of granulocyte colony-stimulating factor plus stem cell factor to mobilize progenitor cells in vivo and stimulation by Flt3/Flk-2 ligand in vitro.. Blood 88(12) : 4452 -4462 1996
    view publication
  • Robb, L, Elwood, NJ, Elefanty, AG, Köntgen, F, Li, R, Barnett, LD, Begley, CG. The scl gene product is required for the generation of all hematopoietic lineages in the adult mouse.. EMBO J 15(16) : 4123 -4129 1996
    view publication
  • Elwood, NJ, Begley, CG. Reconstitution of mice with bone marrow cells expressing the SCL gene is insufficient to cause leukemia.. Cell Growth Differ 6(1) : 19 -25 1995
    view publication
  • Miller, BA, Floros, J, Cheung, JY, Wojchowski, DM, Bell, L, Begley, CG, Elwood, NJ, Kreider, J, Christian, C. Steel factor affects SCL expression during normal erythroid differentiation.. Blood 84(9) : 2971 -2976 1994
    view publication

Page 12 of 14